25.21
View the full transcript and gain access to JoVE Core videos
Q1: What is the main difference between MHC Class I and MHC Class II antigen processing?
MHC Class I molecules present endogenous antigens produced within cells, such as viral or tumor proteins, processed by the proteasome. MHC Class II molecules present exogenous antigens from extracellular sources like bacteria, processed by antigen-presenting cells through phagocytosis. Both pathways generate peptide-MHC complexes displayed on cell surfaces for T cell recognition.
Q2: How does the proteasome contribute to the endogenous antigen pathway?
The proteasome is a cellular machinery that degrades intracellular antigenic proteins from virus-infected or abnormal cells into small peptide fragments. These fragments are then transported into the endoplasmic reticulum, where they bind to newly synthesized MHC I molecules, forming MHC I-peptide complexes for cell surface presentation.
Q3: What role do lysosomes play in exogenous antigen processing?
In the exogenous pathway, antigen-presenting cells engulf pathogens into phagosomes, which fuse with lysosomes to form phagolysosomes. Enzymes within this structure enzymatically degrade the pathogen into smaller peptide fragments. These fragments then bind to MHC II molecules for presentation on the cell surface.
Q4: Why do different cell types process antigens through different pathways?
Most nucleated cells express MHC Class I to present endogenous antigens, enabling detection of internal threats like viruses or tumors. Specialized antigen-presenting cells like dendritic cells express MHC Class II to present exogenous antigens, alerting the immune system to extracellular pathogens. This division allows comprehensive immune surveillance of both internal and external threats.
Q5: How do MHC-peptide complexes trigger an immune response?
T cells recognize MHC-antigen complexes displayed on cell surfaces and initiate an immune response through cytotoxic T cells mediated immune response mechanisms. CD8+ T cells recognize MHC I-peptide complexes on infected cells, while CD4+ T cells recognize MHC II-peptide complexes on antigen-presenting cells, activating appropriate immune defenses.
Q6: What happens to antigens after they are degraded in each pathway?
In the endogenous pathway, peptide fragments are transported into the ER by TAP (transporter associated with antigen processing) and bind MHC I molecules. In the exogenous pathway, peptide fragments are loaded onto MHC II molecules within endosomes or lysosomes. Both complexes then travel to the cell surface via vesicular transport for T cell recognition.
Q7: Which immune cells are responsible for exogenous antigen processing?
Antigen-presenting cells, including dendritic cells, macrophages, and B cells, specialize in exogenous antigen processing. These cells ingest extracellular pathogens through phagocytosis, degrade them enzymatically, and present resulting peptides on MHC II molecules. This process is crucial for immune response against pathogens outside cells.